High-intensity focused ultrasonography (HIFU)—a new thermal ablative therapy—is effective in the treatment of recurrent hepatocellular carcinoma (HCC), new findings have revealed. No differences in tumour size, disease-free survival rates or overall survivial rates were observed between patients with recurrent HCC who underwent HIFU (n = 27) and those who underwent radiofrequency ablation (n = 76) during a median follow up of 27.9 months.
ORIGINAL RESEARCH PAPER
Chan, A. C. Y. et al. Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma. Ann. Surg. doi:10.1097/SLA.0b013e3182822c02
Rights and permissions
About this article
Cite this article
New ablative therapy gives promising results for recurrent hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 10, 196 (2013). https://doi.org/10.1038/nrgastro.2013.47
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2013.47
